Inventor · disambiguated record
Robert Steven Kania
Also filed as: KANIA ROBERT · KANIA ROBERT S · KANIA ROBERT STEVEN
32 granted patents·13 pending applications·920 citations·filing 2001–2023
97Inventor score
Top patents by PatentIndex Score
45 records- 0198US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0298US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0396US11220494B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2020·Granted Jan 11, 2022·13 cites·21 claims
- 0496US9481666B2Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2015·Granted Nov 1, 2016·12 cites·8 claims
- 0596US6531491B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARAMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·200 cites·10 claims
- 0695US10766884B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2019·Granted Sep 8, 2020·19 cites·20 claims
- 0795US8680111B2Macrocyclic derivatives for the treatment of diseasesPFIZER·Filed 2013·Granted Mar 25, 2014·54 cites·18 claims
- 0891US7696213B24-methylpyridopyrimidinone compoundsPFIZER·Filed 2007·Granted Apr 13, 2010·21 cites·16 claims
- 0991US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 1090US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 1189US9133215B2Macrocyclic derivatives for the treatment of diseasesPFIZER·Filed 2014·Granted Sep 15, 2015·16 cites·18 claims
- 1288US8633204B24-methylpyridopyrimidinone compoundsCHENG HENGMIAO·Filed 2012·Granted Jan 21, 2014·11 cites·4 claims
- 1387US10570121B2Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2018·Granted Feb 25, 2020·2 cites·4 claims
- 1487US7732604B2Triazolopyrazine derivativesPFIZER·Filed 2007·Granted Jun 8, 2010·11 cites·11 claims
- 1586US8273755B24-methylpyridopyrimidinone compoundsCHENG HENGMIAO·Filed 2010·Granted Sep 25, 2012·10 cites·15 claims
- 1682US6833456B2Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their useAGOURON PHARMA·Filed 2003·Granted Dec 21, 2004·20 cites·8 claims
- 1781US11684616B2Azalactam compounds as HPK1 inhibitorsPFIZER·Filed 2021·Granted Jun 27, 2023·1 cites·33 claims
- 1881US7053107B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 30, 2006·12 cites·4 claims
- 1979US10125130B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2017·Granted Nov 13, 2018·2 cites·21 claims
- 2075US12378232B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2021·Granted Aug 5, 2025·0 cites·2 claims
- 2175US7381824B2Quinoline derivativesAGOURON PHARMA·Filed 2004·Granted Jun 3, 2008·7 cites·16 claims
- 2275US7208500B2Thienopyridine-phenylacetamides and their derivatives useful as new anti-angiogenic agentsAGOURON PHARMA·Filed 2004·Granted Apr 24, 2007·10 cites·32 claims
- 2374US6869962B2Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their useAGOURON PHARMA·Filed 2003·Granted Mar 22, 2005·6 cites·26 claims
- 2473US10676471B2Cycloalkyl-linked diheterocycle derivativesPFIZER·Filed 2019·Granted Jun 9, 2020·0 cites·2 claims
- 2567US2024197703A1Azalactam Compounds as HPK1 InhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 2663US7045528B2Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their useAGOURON PHARMA·Filed 2004·Granted May 16, 2006·1 cites·30 claims
- 2762US7923457B2Quinoline derivativesAGOURON PHARMA·Filed 2008·Granted Apr 12, 2011·0 cites·4 claims
- 2859US2016376254A1Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2016·Application pending·0 cites
- 2958US2019040055A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2018·Application pending·0 cites
- 3057US7772246B2Pyrazole compounds as RAF inhibitorsPFIZER·Filed 2008·Granted Aug 10, 2010·0 cites·2 claims
- 3157US2017298048A1Substituted dihydroisoquinolinone compoundsPFIZER·Filed 2017·Application pending·0 cites
- 3254US12485157B2Method of treating COVID-19PFIZER·Filed 2021·Granted Dec 2, 2025·0 cites·21 claims
- 3354US12358897B2Compounds and method of treating COVID-19PFIZER·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 3454US2006079548A1Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their useAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 3552US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
- 3651US2006160858A1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 3750US11926642B2Compounds and methods for the treatment of COVID-19PFIZER·Filed 2021·Granted Mar 12, 2024·0 cites·19 claims
- 3848US2017050958A1Cycloalkyl-Linked Diheterocycle DerivativesPFIZER·Filed 2015·Application pending·0 cites
- 3946US2005070508A1Napthalene carboxamides and their derivatives useful as new anti-angiogenic agentsAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 4044US11142525B2Azalactam compounds as HPK1 inhibitorsPFIZER·Filed 2019·Granted Oct 12, 2021·0 cites·40 claims
- 4143US2023157998A1Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019PFIZER·Filed 2021·Application pending·0 cites
- 4242US2010105656A1Triazolopyrazine derivativesPFIZER·Filed 2010·Application pending·0 cites
- 4342US2006014821A1Inhibitors of SARS 3C like proteaseAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 4441US2006094763A1Polymorphic forms of 6-[2-(methylcarbomoyl) phenyl sulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazoleAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 4540US2005267158A1Polymorphic and amorphous forms of 2,5-dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2 pyridin-2-YL-vinyl)-1H-indazol-6-ylamino]-phenyl}-amideAGOURON PHARMA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Steven Kania files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →